Auto-injectable drug maker Aktivax cuts 70 jobs, shuts two sites as it trims scale-up plans
Aktivax Pharma is shutting most operations, closing two out of three facilities and laying off 70 employees due to what the drug auto-injectable manufacturer refers to as “unexpected circumstances.”
“Unfortunately, some of our planning assumptions were not realized and we had to curtail our scale-up plans for the time being, which has led us to reduce our workforce until conditions change,” CEO Amir Genosar said in a statement to Endpoints News.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.